LEXX — Lexaria Bioscience Share News
0.000.00%
Last trade - 00:00- $6.49m
- $2.48m
- $0.71m
Brief: Lexaria's Investigational New Drug Application Filing Update
Brief: Lexaria Bioscience Says On Oct 17 Got Nasdaq Bid Price Deficiency Notice
Brief: Lexaria Bioscience Corp Granted Two New Patents In Canada
RCS - Lexaria Bioscience - Lexaria to Evaluate Impact of DehydraTECH
Brief: Lexaria Bioscience Received Letter Confirming The Cure Of Nasdaq Bid Price Deficiency
Brief: Lexaria Bioscience Granted Strategically Important New Us Patent For Dehydratech-Nicotine Including Oral Pouch Products
Brief: Lexaria Bioscience Corp Gets Notice From Nasdaq That Co Not In Compliance With The $1 Minimum Bid Price Requirement
Brief: Lexaria Bioscience Corp Files For Offering Of Up To 5.3 Million Units, Up To 5.3 Million Pre-Funded Units - SEC Filing
Lexaria Bioscience rises after promising update on its cannabis-based formulation
NASDAQ RESUMED AT 12:06 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:01 PM
NASDAQ RESUMED AT 09:45 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:40 AM
Brief: Lexaria Bioscience Files For Mixed Shelf Of Up To $50 Mln
Lexaria rises after cannabis-based formulation shows promising results in study
U.S. STOCKS ON THE MOVE-Pfizer, PagerDuty, Stitch Fix, Ford
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:59 PM
NASDAQ RESUMED AT 10:36 AM
Lexaria up after drug delivery tech shows possible benefits for COVID-19